Evaluation of Olfactory and Auditory System Effects of the Antihyperthyroid Drug Carbimazole in the Long-Evans Rat

Journal of Biochemical and Molecular Toxicology

Volumn 12, Issue 5, 1998, Pages 305-314

  Genter, Mary Beth ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Acoustic Startle Response; Carbimazole; Flavin Containing Monooxygenase (FMO); Metabolism; Methimazole; Olfactory Mucosa

Indexed keywords

RODENTIA;

3,3' IMINODIPROPIONITRILE; 3,3'-IMINODIPROPIONITRILE; ANTITHYROID AGENT; CARBIMAZOLE; NEUROTOXIN; NITRILE;

ANIMAL; ARTICLE; AUDITORY CORTEX; COMPARATIVE STUDY; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; MALE; METABOLISM; OLFACTORY EPITHELIUM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RAT; STAINING; STARTLE REFLEX;

ADMINISTRATION, ORAL; ANIMALS; ANTITHYROID AGENTS; AUDITORY CORTEX; CARBIMAZOLE; INJECTIONS, INTRAPERITONEAL; LIVER; MALE; NEUROTOXINS; NITRILES; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OLFACTORY MUCOSA; RATS; STAINING AND LABELING; STARTLE REACTION;

EID: 0031616485     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0461(1998)12:5<305::AID-JBT7>3.0.CO;2-P     Document Type: Article

References (60)

1. P. G. Stecher, ed. (1968). The Merck Index, 7th ed., Merck and Co., Rahway, NJ.
2. J. Erikssen, E. Seegaard, and K. Naess (1975). Side-effect of thiocarbamides. Lancet, 1, 231-232.
3. D. Hill, H. Whittet, and H. Simpson (1994). Hearing loss and tinnitus with carbimazole. Br. Med. J., 309, 929.
4. B. Neundorfer (1987). Disorders of smell and taste in treatment with thiamazole and carbimazole. Nervenarzt, 58, 61-62.
5. S. S. Schiffman (1983). Taste and smell in disease (first of two parts). New Engl. J. Med., 308, 1275-1279.
6. M. B. Genter, T. A. Zainal, and N. J. Deamer (1995). Olfactory toxicity of methimazole: results of intraperitoneal and oral dosing studies. In Nasal Toxicity and Dosimetry of Inhaled Xenobiotics: Implications for Human Health, F. J. Miller, ed., Taylor and Francis, Washington, D.C.
7. M. B. Genter, N. J. Deamer, B. L. Blake, D. S. Wesley, and P. E. Levi (1995). Olfactory toxicity of methimazole: dose-response and structure-activity studies, and characterization of flavin-containing monooxygenase activity in the Long-Evans rat olfactory mucosa. Toxicol. Pathol., 23, 477-486.
8. A. P. Farwell and L. E. Braverman (1996). Thyroid and antithyroid drugs. In The Pharmacological Basis of Therapeutics, 9th ed., J. G. Hardman and L. E. Limbird, eds., pp. 1383-1410, McGraw-Hill, New York.
9. F. M. Williams (1985). Clinical significance of esterases in man. Clin. Pharmacokinetics, 10, 392-403.
10. J. P. Kampmann and J. M. Hansen (1981). Clinical pharmacokinetics of antithyroid drugs. Clin. Pharmacokinetics, 6, 401-428.
11. A. R. Dahl and W. M. Hadley (1991). Nasal cavity enzymes involved in xenobiotic metabolism: effects on the toxicity of inhalants, Crit. Rev. Toxicol., 21, 345-372.
12. A. R. Dahl and J. L. Lewis (1993). Respiratory tract uptake of inhalants and metabolism of xenobiotics. Annu. Rev. Pharmacol. Toxicol., 32, 383-407.
13. A. Parkinson (1996). Biotransformation of xenobiotics. In Casarett and Doull's Toxicology, 4th ed., M. O. Amdur, J. Doull, and C. D. Klaassen, eds., pp. 113-186, Pergamon Press, New York.
14. C. J. Reed (1993). Drug metabolism in the nasal cavity: relevance to toxicology. Drug Metab. Rev., 25, 173-205.
15. G. L. Kedderis and D. E. Rickert (1985). Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism: role of flavin-containing monooxygenase. Drug Metab. Disp., 13, 58-61.
16. L. L. Poulson, R. M. Hyslop, and D. M. Ziegler (1979). S-oxidation of N-substituted thioureas catalyzed by the pig liver microsomal FAD-containing monooxygenase. Arch. Biochem. Biophys., 198, 78-88.
17. D. M. Ziegler (1993). Recent studies on the structure and function of multisubstrate flavin containing monooxygenases. Annu. Rev. Pharmacol. Toxicol., 33, 179-199.
18. E. H. Jeffrey and W. M. Haschek (1988). Protection by dimethylsulfoxide against acetaminophen-induced hepatic, but not respiratory toxicity in the mouse. Toxicol. Appl. Pharmacol., 93, 452-461.
19. M. B. Genter, H.-C. Liang, J. Gu, X. Ding, M. Negishi, R. A. McKinnon, and D. W. Nebert. Role of CYP2A5 and 2G1 in acetaminophen metabolism and toxicity in the olfactory mucosa of the Cyp1a2(-/-) mouse. Submitted.
20. E. B. Brittebo, C. Eriksson, and I. Brandt (1990). Activation and toxicity of bromobenzene in nasal tissues in mice. Arch. Toxicol., 64, 54-60.
21. J. Gu, V. E. Walker, T. W. Lipinskas, D. M. Walker, and X. Ding (1997). Intraperitoneal administration of coumarin causes tissue-selective depletion of cytochromes P450 and cytotoxicity in the olfactory mucosa. Toxicol. Appl. Pharmacol., 145, 34-42.
22. E. B. Brittebo, C. Eriksson, V. J. Feil, J. Bakke, and I. Brandt (1991). Toxicity of 2,6-dichlorothiobenzamide (Chlorthiamid) and 2,6-dichlorobenzamide in the olfactory nasal mucosa of mice. Fundam. Appl. Toxicol., 17, 92-102.
23. I. Brandt, E. B. Brittebo, V. J. Feil, and J. E. Bakke (1990). Irreversible binding and toxicity of the herbicide dichlobenil (2,6-dichlorobenzonitrile) in the olfactory mucosa of mice. Toxicol. Appl. Pharmacol., 103, 491-501.
24. N. J. Deamer, J. P. O'Callaghan, and M. B. Genter (1994). Olfactory toxicity resulting from dermal application of 2,6-dichlorobenzonitrile (dichlobenil) in the C57B1 mouse. NeuroToxicology, 15, 287-294.
25. C. J. Reed, L. T. van den Broeke, and F. deMatteis (1989). Drug-induced protoporphyria in the olfactory mucosa of the hamster. J. Biochem. Toxicol., 4, 161-164.
26. N. J. Deamer and M. B. Genter (1995). Olfactory toxicity of diethyldithiocarbamate (DDTC) and disulfiram and the protective effects of DDTC against the olfactory toxicity of dichlobenil. Chem.-Biol. Interact., 95, 215-226.
27. G. J. Schiferstein, W. G. Sheldon, S. A. Cantrell, and G. Reddy (1988). Subchronic toxicity of 1,4-dithiane in the rat. Fundam. Appl. Toxicol., 11, 703-714.
28. K. M. Crofton, X. Zhao, L. M. Sayer, and M. B. Genter (1996). Characterization of the effects of N-hydroxy-IDPN on the auditory, vestibular, and olfactory systems in rats. Neurotoxicol. Teratol., 18, 297-303.
29. M. B. Genter, J. Llorens, J. P. O'Callaghan, D. B. Peele, K. T. Morgan, and K. M. Crofton (1992). Olfactory toxicity of β, β′-iminodipropionitrile (IDPN) in the rat. J. Pharmacol. Exp. Therap., 263, 1432-1439.
30. M. A. M. Turk, W. Flory, and W. Henk (1986). Chemical modulation of 3-methylindole toxicosis in mice: effects on bronchiolar and olfactory mucosal injury. Vet. Pathol., 23, 563-570.
31. M. A. M. Turk, W. Henk, and W. Flory (1987). 3-Methylindole-induced nasal mucosal damage in mice. Vet. Pathol., 24, 400-403.
32. R. K. Jensen and S. D. Sleight (1987). Toxic effects of N-nitrosodiethylamine on nasal tissues of Sprague-Dawley rats and golden Syrian hamsters. Fundam. Appl. Toxicol., 8, 217-229.
33. M. B. Genter and K. M. Crofton. 2-Pentenenitrile. In Experimental and Clinical Neurotoxicology, 2nd ed., P. S. Spencer and H. H. Schaumburg, eds., Oxford University Press, in press.
34. M. S. Bogdanffy, T. J. Mazaika, and W. J. Fasano (1989). Early cell proliferative effects of phenacetin on rat nasal mucosa. Toxicol. Appl. Pharmacol., 98, 100-112.
35. R. Jansson, P. A. Dahlberg, H. Johansson, and B. Lindstrom (1983). Intrathyroidal concentrations of methimazole in patients with Graves' disease. J. Clin. Endocrinol. Metab., 57, 129-132.
36. A. Shiroozu, K. Okamura, H. Ikenoue, K. Sato, T. Nakashima, M. Yoshinari, M. Fujishima, and T. Yoshizumi (1986). Treatment of hyperthyroidism with a small daily dose of methimazole. J. Clin. Endocrinol. Metab., 63, 125-128.
37. E. M. Faustman and G. S. Omenn (1996). Risk assessment. In Casarett and Doull's Toxicology, 4th ed., M. O. Amdur, J. Doull, and C. D. Klaassen, eds., pp. 75-88, Pergamon Press, New York.
38. J. S. Young and L. D. Fechter (1983). Reflex inhibition procedures for animal audiometry: a technique for assessing ototoxicity. J. Acoust. Soc. Am., 73, 1686-1693.
39. K. M. Crofton and T. Knight (1991). Auditory deficits and motor dysfunction following iminodipropionitrile administration in the rat. Neurotoxicol. Teratol., 13, 575-581.
40. K. M. Crofton and X. Zhou (1993). Mid-frequency hearing loss in rats following inhalation exposure to trichloroethylene: evidence from reflex modification audiometry. Neurotoxicol. Teratol., 15, 413-423.
41. R. M. Jaspers, H. Muijser, J. H. Lammers, and B. M. Kulig (1993). Mid-frequency hearing loss and reduction of acoustic startle response in rats following trichloroethylene exposure. Neurotoxicol. Teratol., 15, 407-412.
42. K. M. Crofton, R. Janssen, J. Prazma, S. Pulver, and S. Barone (1994). The ototoxicity of 3,3′-iminodipropionitrile: functional and morphological evidence of cochlear damage. Hear. Res., 80, 129-140.
43. K. M. Crofton, T. L. Lassiter, and C. S. Rebert (1994). Solvent-induced ototoxicity in rats: an atypical selective mid-frequency hearing deficit. Hear Res., 80, 25-30.
44. E. S. Goldey, J. P. O'Callaghan, M. E. Stanton, S. Barone, and K. M. Crofton (1994). Developmental neurotoxicity: evaluation of testing procedures with methylazoxymethanol and methylmercury. Fundam. Appl. Toxicol., 23, 447-464.
45. J. R. Prohaska and R. G. Hoffman (1996). Auditory startle response is diminished in rats after recovery from perinatal copper deficiency. J. Nutr., 126, 618-627.
46. H. Seligmann, L. Podoshin, J. Ben-David, M. Fradis, and M. Goldsher (1996). Drug-induced tinnitus and other hearing disorders. Drug Safety, 14, 198-212.
47. E. Wallhausser-Franke, S. Braun, and G. Langer (1996). Salicylate alters 2-DG uptake in the auditory system: a model for tinnitus? Neuroreport, 7, 1585-1588.
48. J. Llorens, D. Dememes, and A. Sans (1993). The behavioral syndrome caused by 3,3′-iminodipropionitrile and related nitriles is associated with degeneration of the vestibular sensory hair cells. Toxicol. Appl. Pharmacol., 123, 199-210.
49. J. A. Paterson and E. W. Hosea (1993). Auditory behaviour and brainstem histochemistry in adult rats with characterized ear damage after neonatal ossicle ablation or mcochlear disruption. Behav. Brain Res., 53, 73-89.
50. Y. Kimura, H. Miwa, M. Furukawa, and Y. Mizukami (1996). Relapsing polychondritis presented as inner ear involvement. J. Laryngol. Otol., 110, 154-157.
51. M. D. Seidman and G. P. Jacobson (1996). Update on tinnitus. Otolaryngolic Clinics of North America, 29, 455-465.
52. J. T. Young (1981). Histopathologic examination of the rat nasal cavity. Fundam. Appl. Toxicol., 1, 309-312.
53. H. L. Harter (1960). Critical values for Duncan's new multiple range test. Biometrics, 16, 671-685.
54. S. Gad and C. S. Weil, eds. (1988). Statistics and Experimental Design for Toxicologists, 2nd ed., 376 pp., The Telford Press, Caldwell, NJ.
55. A. Taurog (1976). The mechanism of action of the thioureylene antithyroid drugs. Endocrinology, 98, 1031-1046.
56. X. Ding, D. C. Sprink, J. K. Bhama, J. J. Sheng, A. D. Vaz, and M. J. Coon (1996). Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450. Mol. Pharmacol., 49, 1113-1121.
57. K. M. Crofton (1992). Reflex modification and the assessment of sensory dysfunction. In Neurotoxicology, H. Tilson and C. Mitchell, eds., pp. 181-211, Raven Press, New York.
58. J. S. Yeomans and P. W. Frankland (1996). The acoustic startle reflex: neurons and connections, Brain Res. Rev., 21, 301-314.
59. J. Blaszczyk and K. Tajchert (1996). Sex and strain differences of acoustic startle reaction development in adolescent albino Wistar and hooded rats. Acta Neurobiologiae Experimentalis (Warsz), 56, 919-925.
60. P. Brown, B. L. Day, J. C. Rothwell, P. D. Thompson, and C. D. Marsden (1991). The effect of posture on the normal and pathological auditory startle reflex. J. Neurol. Neurosurg. Psychiatry, 54, 892-897.